These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4447969)

  • 1. [Statistical evaluation of the vaccine quality (author's transl)].
    Josífko M
    Cas Lek Cesk; 1974 Dec; 113(52):1600-3. PubMed ID: 4447969
    [No Abstract]   [Full Text] [Related]  

  • 2. [Observations on the reactions and preventive efficacy of lyophilized group A meningococcal polysaccharide vaccine (author's transl)].
    Song BH; Liu DG
    Zhonghua Yu Fang Yi Xue Za Zhi; 1982 Jan; 16(1):39-41. PubMed ID: 6807642
    [No Abstract]   [Full Text] [Related]  

  • 3. [Smallpox vaccine--2. Preparation of vaccine (author's transl)].
    Slonim D; Stastný F; Brázdová R
    Cesk Epidemiol Mikrobiol Imunol; 1977 Jul; 26(4):227-34. PubMed ID: 145908
    [No Abstract]   [Full Text] [Related]  

  • 4. Quality-control issues and approaches in vaccine development.
    Metz B; van den Dobbelsteen G; van Els C; van der Gun J; Levels L; van der Pol L; Rots N; Kersten G
    Expert Rev Vaccines; 2009 Feb; 8(2):227-38. PubMed ID: 19196202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Properties of the lyophilized anti-swine-erysipelas vaccine (VR2)].
    Bodurova Ts
    Vet Med Nauki; 1973; 10(9):65-9. PubMed ID: 4792313
    [No Abstract]   [Full Text] [Related]  

  • 6. [Findings of toxoplasmatic antibodies in man and animals after application of a lyophylized vaccine against rabies (author's transl)].
    Hübner J; Havránková D; Uhlíková M; Kouba K; Zástĕra M
    Cesk Epidemiol Mikrobiol Imunol; 1980 Jan; 29(1):46-51. PubMed ID: 6445786
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new rabies vaccine for human use prepared in primary tissue culture (author's transl)].
    Atanasiu P; Tsiang H; Gamet A
    Ann Microbiol (Paris); 1974; 125B(3):419-32. PubMed ID: 4463760
    [No Abstract]   [Full Text] [Related]  

  • 8. Statistical considerations for vaccine immunogenicity trials. Part 2: Noninferiority and other statistical approaches to vaccine evaluation.
    Plikaytis BD; Carlone GM
    Vaccine; 2005 Feb; 23(13):1606-14. PubMed ID: 15694513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New challenges in assuring vaccine quality.
    Dellepiane N; Griffiths E; Milstien JB
    Bull World Health Organ; 2000; 78(2):155-62. PubMed ID: 10743279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assuring the quality and safety of vaccines: regulatory licensing and batch release.
    Griffiths E; Knezevic I
    Methods Mol Med; 2003; 87():353-76. PubMed ID: 12958467
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the xerovac process for the preparation of heat tolerant contagious bovine pleuropneumonia (CBPP) vaccine.
    Litamoi JK; Ayelet G; Rweyemamu MM
    Vaccine; 2005 Apr; 23(20):2573-9. PubMed ID: 15780439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality assessment of nonanthrax vaccination data in the Defense Medical Surveillance System (DMSS), 1998-2004.
    Davila JC; Payne DC; Zhang Y; Rose CE; Aranas A; Hill AN; Ruscio B; McNeil MM
    Vaccine; 2008 Mar; 26(12):1577-84. PubMed ID: 18295379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of editorial peer review in the evaluation of vaccine safety.
    Jefferson T
    Vaccine; 2004 May; 22(15-16):2073-5. PubMed ID: 15121326
    [No Abstract]   [Full Text] [Related]  

  • 14. [Aminoacids and similar protective molecules for hemoglobin upon freeze-drying (author's transl)].
    Labrude P; Vigneron C; Artur Y; Saint-Blancard J
    Ann Pharm Fr; 1980; 38(3):271-7. PubMed ID: 7425479
    [No Abstract]   [Full Text] [Related]  

  • 15. Testing vaccine potency.
    John TJ
    Indian Pediatr; 2000 Dec; 37(12):1387. PubMed ID: 11119348
    [No Abstract]   [Full Text] [Related]  

  • 16. Statistical evaluation of numbers of animals to be used in vaccine potency testing: a practical approach.
    Akkermans AM; Hendriksen CF
    Dev Biol Stand; 1999; 101():255-60. PubMed ID: 10566799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developments in the reduction refinement and replacement of animal tests in the quality control of immunobiologicals.
    Kreeftenberg JG
    Dev Biol Stand; 1999; 101():13-7. PubMed ID: 10566769
    [No Abstract]   [Full Text] [Related]  

  • 18. Moisture measurement: a new method for monitoring freeze-drying cycles.
    Bardat A; Biguet J; Chatenet E; Courteille F
    J Parenter Sci Technol; 1993; 47(6):293-9. PubMed ID: 8120734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comments on 'Sample size for equivalence trials: A case study from a vaccine lot consistency trial' by J. Ganju, A. Izu and A. Anemona, Statistics in Medicine 2008; 27:3743-3754.
    Kohberger RC
    Stat Med; 2009 Jan; 28(1):177-8, author reply 178-9. PubMed ID: 18937271
    [No Abstract]   [Full Text] [Related]  

  • 20. [An oral enteritis-vaccine composed of twelve heat-inactivated Enterobacteriaceae 3. Communication: studies on efficacy tests in mice protection tests (author's transl)].
    Raettig H
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):511-20. PubMed ID: 7036591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.